Lichen International LTD (LICN) — SEC Filings

Overview

Lichen International LTD (LICN) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Dec 11, 2025: Lichen International Limited filed a Form 6-K on December 11, 2025, for the month ended December 2025. The filing includes a Notice of Extraordinary General Meeting of shareholders. The company's principal executive office is located in Xiamen City, Fujian Province, China.

Sentiment Summary

Across 29 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 26 neutral. The dominant filing sentiment for Lichen International LTD is neutral.

Filing Type Overview

Lichen International LTD (LICN) has filed 27 6-K, 2 20-F with the SEC between Feb 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (29)

• Lichen International Ltd Files 6-K for Shareholder Meeting — 6-K · Dec 11, 2025 Risk: low
  Lichen International Limited filed a Form 6-K on December 11, 2025, for the month ended December 2025. The filing includes a Notice of Extraordinary General Mee
• Lichen International Ltd. Adopts 2025 Equity Incentive Plan — 6-K · Nov 7, 2025 Risk: low
  Lichen International Limited announced its 2025 Equity Incentive Plan, approved by its Board of Directors on October 30, 2025, and effective the same day. This
• Lichen International Ltd Enters Securities Purchase Agreements — 6-K · Sep 19, 2025 Risk: low
  On September 15, 2025, Lichen International Limited entered into securities purchase agreements with certain investors. The company, formerly known as Lichen Ch
• Lichen International Ltd. Settles Debt with CEO Ya Li — 6-K · Sep 10, 2025 Risk: low
  On August 27, 2025, Lichen International Ltd. entered into a debt settlement and mutual release agreement with its CEO, Chairman, and Director, Mr. Ya Li. The a
• Lichen International Ltd Files 2024 Annual Report — 20-F · Apr 29, 2025 Risk: medium
  Lichen International Ltd filed its annual report on Form 20-F for the fiscal year ended December 31, 2024. The company, previously known as Lichen China Ltd unt
• Lichen International Ltd Director Resigns — 6-K · Apr 4, 2025 Risk: low
  On April 2, 2025, Ms. Lourdes Felix resigned as a director and Chair of the Audit Committee of Lichen International Ltd. Her resignation was effective immediate
• Lichen International Ltd. Files March 2025 6-K Report — 6-K · Mar 20, 2025 Risk: medium
  Lichen International Ltd. (the "Company") filed a Form 6-K on March 20, 2025, reporting its activities for the month ended March 2025. The filing references a d
• Lichen China Ltd. Reverse Stock Split & Name Change Effective March 3 — 6-K · Feb 28, 2025 Risk: medium
  Lichen China Limited announced on February 27, 2025, that its previously disclosed 1-for-10 reverse stock split and name change to "Lichen International Limited
• Lichen China Buys Bondly Enterprise for $1M — 6-K · Feb 26, 2025 Risk: medium
  On February 7, 2025, Lichen China Limited entered into a Share Purchase Agreement with Zisu Zhou to acquire 100% of the issued and outstanding share capital of
• Lichen China Faces Nasdaq Delisting Risk Over Bid Price — 6-K · Feb 18, 2025 Risk: medium
  Lichen China Limited received a letter from Nasdaq on February 12, 2025, indicating a deficiency in meeting the minimum bid price requirement for continued list
• Lichen China Ltd Holds Annual Shareholder Meeting — 6-K · Feb 12, 2025 Risk: low
  Lichen China Limited held its Annual Meeting of Shareholders on February 10, 2025. The meeting took place at 09:00 PM China Time (08:00 AM Eastern Time) at the
• Lichen China Acquires Bondly Enterprises for AI Growth — 6-K · Feb 10, 2025 Risk: medium
  Lichen China Limited announced on February 10, 2025, that it has acquired the remaining equity in Bondly Enterprises. This strategic move aims to strengthen Lic
• Lichen China Integrates DeepSeek AI for Financial Services — 6-K · Feb 3, 2025 Risk: low
  Lichen China Limited announced on January 28, 2025, that it will integrate DeepSeek Optimization into its Financial and Taxation AI Model. This integration aims
• Lichen China Ltd. Announces Registered Direct Offering — 6-K · Jan 31, 2025 Risk: medium
  Lichen China Limited announced on January 28, 2025, that it entered into a securities purchase agreement for a registered direct offering with certain instituti
• Lichen China Faces Nasdaq Delisting Warning — 6-K · Jan 27, 2025 Risk: medium
  Lichen China Limited received a notification from Nasdaq on January 23, 2025, stating it is not in compliance with the minimum bid price requirement. The compan
• Lichen China Ltd. Files 6-K for January 2025 — 6-K · Jan 21, 2025 Risk: low
  Lichen China Ltd. filed a Form 6-K on January 21, 2025, for the month ended January 2025. The filing indicates the company is a foreign private issuer and will
• Lichen China Ltd. Announces Registered Direct Offering — 6-K · Jan 3, 2025 Risk: medium
  Lichen China Limited announced a registered direct offering on December 26, 2024, entering into a securities purchase agreement with certain institutional inves
• Lichen China Ltd. Enters Securities Purchase Agreement — 6-K · Dec 17, 2024 Risk: medium
  On December 12, 2024, Lichen China Limited entered into a securities purchase agreement with certain institutional investors. The filing does not specify the do
• Lichen China Issues 1.15M Shares for Employee Compensation — 6-K · Nov 21, 2024 Risk: low
  On November 18, 2024, Lichen China Limited issued 1,150,000 Class A ordinary shares under its 2023 Equity Incentive Plan. These shares were granted as compensat
• Lichen China Ltd Files 6-K with Financial Update — 6-K · Sep 24, 2024 Risk: medium
  Lichen China Limited filed a Form 6-K on September 24, 2024, reporting on its financial condition and results of operations for the period ending June 30, 2024.
• Lichen China Ltd Enters Share Purchase Agreement — 6-K · Jul 18, 2024 Risk: low
  Lichen China Limited announced on July 18, 2024, that it entered into a Share Purchase Agreement on March 9, 2023, with Zisu Zhou, a national of the People's Re
• Lichen China Closes Registered Direct Offering — 6-K · May 13, 2024 Risk: low
  Lichen China Limited announced the closing of its registered direct offering on May 13, 2024, which was previously disclosed on May 6, 2024. The offering was in
• Lichen China Ltd Enters Securities Purchase Agreements — 6-K · May 6, 2024 Risk: medium
  On May 2, 2024, Lichen China Limited entered into Securities Purchase Agreements with eight unrelated third-party purchasers. The agreements detail the terms fo
• Lichen China Ltd Reports FY 2023 Financial Results — 6-K · Apr 5, 2024 Risk: low
  Lichen China Limited announced its financial results for the fiscal year ended December 31, 2023, on April 5, 2024. The company, which provides management consu
• Lichen China Ltd Files Annual Report on Form 20-F for Fiscal Year Ended December 31, 2023 — 20-F · Apr 4, 2024 Risk: low
  Lichen China Ltd (LICN) filed a Foreign Annual Report (20-F) with the SEC on April 4, 2024. Lichen China Ltd filed its annual report on Form 20-F for the fiscal
• Lichen China Launches AI Software for Finance & Tax — 6-K · Mar 25, 2024 Risk: low
  Lichen China Limited announced on March 25, 2024, the launch of its new AI-powered software designed to provide financial and taxation solutions. This new offer
• Lichen China Ltd Expands International Market Presence — 6-K · Mar 15, 2024 Risk: low
  Lichen China Limited issued a press release on March 14, 2024, announcing its expansion into international markets. The company is headquartered in Xiamen City,
• Lichen China Appoints Robert Bodenstein as Director — 6-K · Feb 27, 2024 Risk: low
  Lichen China Limited announced on February 26, 2024, the appointment of Mr. Robert Bodenstein as a director. This appointment was approved by the Board of Direc
• Lichen China Ltd. Dismisses Auditor TPS Thayer, LLC — 6-K · Feb 6, 2024
  Lichen China Limited, a Chinese management consulting firm, announced on February 6, 2024, that it dismissed its independent registered public accounting firm,

Risk Profile

Risk Assessment: Of LICN's 28 recent filings, 0 were flagged as high-risk, 12 as medium-risk, and 16 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

• Mr. Ya Li
• Ms. Lourdes Felix
• Zisu Zhou
• Mr. Robert Bodenstein

Industry Context

Lichen China Ltd operates within the Management Consulting Services industry, providing services to businesses.

Top Tags

foreign-private-issuer (6) · financing (5) · corporate-governance (4) · sec-filing (3) · offering (3) · shareholder-meeting (2) · employee-compensation (2) · 20-F (2) · regulatory-filing (2) · compliance (2)

Key Numbers

• Fiscal Year End: 2024 — The period covered by the annual report.
• SEC File Number: 001-41493 — Identifies the company's filing history with the SEC.
• Central Index Key: 0001876766 — Unique identifier for the company in the SEC's EDGAR system.
• Reverse Stock Split Ratio: 1-for-10 — This ratio indicates that for every 10 shares held, shareholders will have 1 share after the split.
• Purchase Price: $1.0M — Cash paid for 100% of Bondly Enterprise Limited
• Minimum Bid Price: $1.00 — Required for continued Nasdaq listing
• Class A ordinary shares: 1,150,000 — Issued as compensation to employees
• Class A Ordinary Shares outstanding: 17,500,000 — As of December 31, 2023
• Class B Ordinary Shares outstanding: 9,000,000 — As of December 31, 2023
• Annual Compensation: US$5,000 — for Mr. Robert Bodenstein as director
• Appointment Date: February 26, 2024 — effective date of director appointment

Related Companies

LICH

Frequently Asked Questions